C12N 5/06
Animal cells or tissues
Official title: {Animal cells or tissues; Human cells or tissues (preservation of excised living parts A01N1/10)}
C12N5/06 (Animal cells or tissues) appears on 16,958 US grants and 36,019 published applications in this corpus.
Search patents in C12N- Granted patents
- 16,958
- Published applications
- 36,019
- Assignees
- 8,071
- Inventors
- 48,854
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 4 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 4 | 0 |
| 1984 | 7 | 0 |
| 1985 | 5 | 0 |
| 1986 | 4 | 0 |
| 1987 | 8 | 0 |
| 1988 | 6 | 0 |
| 1989 | 13 | 0 |
| 1990 | 12 | 0 |
| 1991 | 15 | 0 |
| 1992 | 31 | 0 |
| 1993 | 35 | 0 |
| 1994 | 52 | 0 |
| 1995 | 52 | 0 |
| 1996 | 82 | 0 |
| 1997 | 132 | 0 |
| 1998 | 195 | 0 |
| 1999 | 174 | 0 |
| 2000 | 158 | 0 |
| 2001 | 181 | 107 |
| 2002 | 175 | 456 |
| 2003 | 190 | 1464 |
| 2004 | 143 | 565 |
| 2005 | 149 | 673 |
| 2006 | 208 | 626 |
| 2007 | 302 | 664 |
| 2008 | 285 | 681 |
| 2009 | 235 | 747 |
| 2010 | 309 | 915 |
| 2011 | 311 | 935 |
| 2012 | 427 | 971 |
| 2013 | 474 | 1105 |
| 2014 | 650 | 1141 |
| 2015 | 723 | 1282 |
| 2016 | 721 | 1399 |
| 2017 | 788 | 1565 |
| 2018 | 894 | 1677 |
| 2019 | 1032 | 2175 |
| 2020 | 1093 | 2273 |
| 2021 | 1095 | 2429 |
| 2022 | 1049 | 2707 |
| 2023 | 1101 | 2530 |
| 2024 | 1202 | 2710 |
| 2025 | 1276 | 2423 |
| 2026 | 945 | 1799 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Meat flavouring6 Oct 2026US 12,751,473 B2Ants Innovate Pte. Ltd.
- Engineered cells and uses thereof6 Oct 2026US 12,751,929 B2Ohio State Innovation Foundation
- Anti-Claudin18.2 antigen-binding fragment or antibody, and use thereof182551196 Oct 2026US 12,751,972 B2Guangzhou Bio-Gene Technology Co., Ltd
- Bispecific chimeric antigen receptors targeting CD20 and BCMA6 Oct 2026US 12,751,973 B2Abelzeta Inc.
- Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke6 Oct 2026US 12,751,976 B2The Regents of the University of California
- Intranasal delivery of cd34+ cells for the treatment of stroke8 Oct 2026US 2026/0306537 A1Cellprothera
- Application of CCR5hi Innate Immune Memory Cells in Preparation of Immunotherapeutic Drug for Treating Sepsis8 Oct 2026US 2026/0306538 A1Children's Hospital of Soochow University
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Novel phosphoantigen prodrug compound and use thereof8 Oct 2026US 2026/0306541 A1
- Targeted Immune Cell Therapy Utilizing TRAIL and TNF Mediated Apoptosis8 Oct 2026US 2026/0306542 A1Northeastern University
Most cited
By later US patents
- Renewable neural implant device and method1,456US 5,554,148 ABrown University Research Foundation · 1996
- Plasma protein matrices and methods for their preparation1,406US 7,009,039 B2ProChon Biotech Ltd. · 2006
- Interleukin-1α antibodies1,029US 8,034,337 B2Xbiotech, Inc. · 2011
- Biocompatible devices with foam scaffolds984US 6,054,142 ACyto Therapeutics, Inc. · 2000
- Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers896US 5,410,016 ABoard of Regents, The University of Texas System · 1995